Our patients can schedule a COVID-19 vaccination through NYU Langone Health MyChart or the NYU Langone Health app. Learn more about the COVID-19 vaccine. Read our updated information about wearing a mask for your visit.

If you need help accessing our website, call 855-698-9991
Skip to main content
Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.

Michael Engelbert, MD, PhD

Affiliated Provider
Affiliated providers provide medical care at an NYU Langone location or a private practice, and are not employed by NYU Langone Health.
  • Specialties: Retinal Ophthalmology, Ophthalmology
  • Languages: English, French, German, Italian, Spanish
  • Phone: 212-861-9797
View Locations

Conditions and Treatments

Conditions
  • diabetic retinopathy
  • eye floater
  • eye injury
  • macular degeneration
  • retinal artery occlusion
  • retinal detachment
  • retinoblastoma
  • retinopathy
Treatments
  • eye surgery
  • retinal surgery

Board Certifications
  • American Board of Ophthalmology - Ophthalmology, 2011
Education and Training
  • Fellowship, Columbia University/VRMNY/Manhattan Eye Ear and Throat Hospital, Vitreoretinal Dis., 2010
  • Residency, Columbia University College of Physicians & Surgeons, Ophthalmology, 2008
  • PhD from University Of Oklahoma, 2004
  • MD from Ludwig-Maximillian University, 1999

Is this your profile?

Edit profile

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Cigna
    • Cigna EPO/POS
    • Cigna PPO
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
    • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Family Health
    • Fidelis Medicaid
    • Fidelis Medicare
  • MultiPlan/PHCS
    • MultiPlan/PHCS PPO
  • NYS Health Insurance Plan
    • The Empire Plan
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • UHC
    • UnitedHealthcare Community & State Plan
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
View All Accepted Plans This list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.

Locations and Appointments

Vitreous Retina Macula Consultants of NY

460 Park Avenue, 5th Floor
New York, NY 10022

Vitreous Retina Macula Consultants of NY

902 Quentin Road, Suite 601
Brooklyn, NY 11223

Vitreous Retina Macula Consultants of NY

244 Westchester Avenue, Suite 407
Harrison, NY 10604

Vitreous Retina Macula Consultants of NY, P.C.

950 3rd Ave, 3rd Fl
New York, NY 10022

Interests

bacterial endophthalmitis, staphylococcus aureus infection

Research Summary

The incidence of endophthalmitis, a potentially blinding infection of the interior of the eye is becoming an ever more important public health problem, since intraocular procedures have experienced exponential growth in recent years. The molecular pathogenesis of endophthalmitis (and many other bacterial infections) is poorly understood, and potential therapeutic avenues therefore remain unexplored. S. aureus is the most important cause of severe endophthalmitis (and many other sever infections), with less than half of patients regaining vision better than 20/200, the cutoff for legal blindness. S. aureus will be the focus of the proposed research. The overarching goal of this project is to characterize the organisms causing severe ocular S. aureus infections, and use endophthalmitis as a model of disease that affords an unparalleled view of the mechanisms involved in the molecular pathogenesis of bacterial infection. The specific goals of this project are to (i) collect and characterize bacterial isolates from ocular infections in a collaborative fashion both locally, nationally and internationally, and characterize them on the molecular level, (ii) analyze the host-pathogen interactions that lead to an untoward outcome in S. aureus endophthalmitis by employing genetically modified bacterial strains and knockout host organisms in animal models developed by the principal investigator, and (iii) therapeutically modulate bacterial gene expression and the host response based on the knowledge gleaned from (i) and (ii) to improve visual outcome of patients with endophthalmitis, or other severe staphylococcal infections. The principal investigator has an established network of collaborators both on the NYU Campus (R.Novick Ph.D., B. Shopsin M.D.) and outside of NYU both in New York (R. Rosen M.D., NYEE; S.C. Chang M.D., Columbia University) and outside (M.S. Gilmore Ph.D., Harvard University; H. Flynn M.D., Bascom Palmer Eye Institute; H. Mi?o de Kaspar Ph.D., Stanford University and Munich University, Germany) that allows for collaborative collection of bacterial strains and to monitor emerging etiologic trends nationally and internationally.

These focus areas and their associated publications are derived from PubMed and the MeSH term library. *
represents one publication
Loading...
*Due to PubMed processing times, the most recent publications may not be reflected in the timeline.

Read All Publications (71)